Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-κB activation

Journal of Molecular Medicine

Volumn 85, Issue 6, 2007, Pages 635-645

  De Filippis, Daniele ^a   Russo, Annapina ^a   De Stefano, Daniela ^a   Maiuri, Maria Chiara ^a   Esposito, Giuseppe ^a   Cinelli, Maria Pia ^a   Pietropaolo, Concetta ^a   Carnuccio, Rosa ^a   Russo, Giulia ^a   Iuvone, Teresa ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Angiogenesis; Cannabinoids; Chronic inflammation; Nuclear factor kappa B

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ARACHIDONYL 2 CHLOROETHYLAMIDE; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; CANNABIS; CARRAGEENAN; CYCLOOXYGENASE 2; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; RIMONABANT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; DNA BINDING; DNA DETERMINATION; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; ENZYME ACTIVITY; IMPLANTATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; TUMOR VOLUME; WESTERN BLOTTING;

ANALGESICS; ANIMALS; BENZOXAZINES; CARRAGEENAN; CELL MOVEMENT; CELL NUCLEUS; GENE EXPRESSION REGULATION; GRANULOMA; LEUKOCYTES; MALE; MORPHOLINES; NAPHTHALENES; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROTEIN TRANSPORT; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; TIME FACTORS;

EID: 34249866863     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0188-z     Document Type: Article

References (34)

1. Drapier JC, Petit JF (1986) Development of antitumor activity in LPS-stimulated mouse granuloma macrophage regulation by eicosanoids. Inflammation 10:195-204
2. Colville-Nash PR, Alam CA, Appleton I, Brown JR, Seed MP, Willoughby DA (1995) The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J Pharmacol Exp Ther 274:1463-1472
3. Risau W (1997) Mechanisms of angiogenesis. Nature 386:671-674
4. Jackson JR, Bolognese B, Kircher CH, Marshall LA, Winkler JD (1997) Modulation of angiogenesis in a model of chronic inflammation. Inflamm Res 46:129-130
5. Kobayashi SD, Voyich JM, Braughton KR, Whitney AR, Nauseef WM, Malech HL, DeLeo FR (2004) Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 172:636-643
6. Tripp CS, Needleman P, Kassab JT, Weinstock JV (1988) Macrophages isolated from liver granulomas of murine Schistosoma mansoni synthesize predominantly TxA2 during the acute and chronic phases of infection. J Immunol 140:3140-3143
7. Martin-Padura I, De Castellarnau C, Uccini S, Pilozzi E, Natali PG, Nicotra MR, Ughi F, Azzolini C, Dejana E, Ruco L (1995) Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas. J Pathol 175:51-57
8. Russo A, Russo G, Peticca M, Pietropaolo C, Di Rosa M, Iuvone T (2004) Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5. Br J Pharmacol 145:24-33
9. Brown JF, Chafee KA, Tepperman BL (1998) Role of mast cells, neutrophils and nitric oxide in endotoxin-induced damage to the neonatal rat colon. Br J Pharmacol 123:31-38
10. Maiuri MC, Tajana G, Iuvone T, De Stefano D, Mele G, Ribecco MT, Cinelli MP, Romano MF, Turco MC, Carnuccio R (2004) Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model. Am J Pathol 165:115-126
11. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18:621-663
12. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA (1994) Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 91:2046-2050
13. Kawachi S, Cockrell A, Laroux FS, Gray L, Granger DN, van der Heyde HC, Grisham MB, van der Heyde HC (1999) Role of inducible nitric oxide synthase in the regulation of VCAM-1 expression in gut inflammation. Am J Physiol 277:572-576
14. Campbell KJ, Perkins ND (2006) Regulation of NF-kappaB function. Biochem Soc Symp 73:165-180
15. Nocerino E, Amato M, Izzo AA (2002) Cannabis and cannabinoid receptors. Fitoterapia 71:6-12
16. Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389-462
17. Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 129-180
18. Matias I, Pochard P, Orlando P, Salzet M, Pestel J, Di Marzo V (2002) Presence and regulation of the endocannabinoid system in human dendritic cells. Eur J Biochem 269:3771-3778
19. Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS (2004) Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. J Immunol 173:2373-2382
20. Sacerdote P, Massi P, Panerai AE, Parolaro DJ (2000) In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. Neuroimmunology 109:155-163
21. Klein TW (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5:400-411
22. Klein TW, Newton C, Larsen K, Chou J, Perkins I, Lu L, Nong L, Friedman H (2004) Cannabinoid receptors and T helper cells. J Neuroimmunol 147:91-94
23. Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I (2006) Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA 103:696-701
24. Ross RA, Brockie HC, Pertwee RG (2000) Inhibition of nitric oxide production in RAW 264.7 macrophages by cannabinoids and palmitoylethanolamide. Eur J Pharmacol 401:121-130
25. Costa B, Colleoni M, Conti S, Parolaro D, Franke C, Trovato AE, Giagnoni G (2004) Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn Schmiedebergs Arch Pharmacol 369:294-299
26. Mbvundula EC, Bunning RA, Rainsford KD (2006) Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1alpha-induced matrix degradation in bovine articular chondrocytes in-vitro. J Pharm Pharmacol 58:351-358
27. Blazquez C, Casanova ML, Planas A, Del Pulgar TG, Villanueva C, Fernandez-Acenero MJ, Aragones J, Huffman JW, Jorcano JL, Guzman M (2003) Inhibition of tumor angiogenesis by cannabinoids. FASEB J 7:529-531
28. Muramtsu M, Katada J, Hayashi I, Majama M (2000) Chymase as a proangiogenic factor. A possible involvement of chymase angiotensin dependent pathway in the hamster sponge angiogenesis model. J Biol Chem 275:5545-5552
29. Mullane KM, Kraemer R, Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157-167
30. Gramolini AO, Belanger G, Thompson JM, Chakkalakal JV, Jasmin BJ (2001) Increased expression of utrophin in a slow vs a fast muscle involves posttranscriptional events. Am J Physiol Cell Physiol 281:1300-1309
31. Sancho R, Calzado MA, Di Marzo V, Appendino G, Munoz E (2003) Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway. Mol Pharmacol 63:429-438
32. Juttler E, Potrovita I, Tarabin V, Prinz S, Dong-Si T, Fink G, dSchwaninger M (2004) The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B). Neuropharmacology 47:580-592
33. Esposito G, De Filippis D, Maiuri MC, De Stefano D, Carnuccio R, Iuvone T (2006) Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett 399:91-95
34. Samson MT, Small-Howard A, Shimoda LM, Koblan-Huberson M, Stokes AJ, Turner HJ (2003) Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol 170:4953-4962